Clinical observation on therapeutic effects of acupuncture treatment for 100 cases of type II diabetes

2004 ◽  
Vol 2 (6) ◽  
pp. 34-35 ◽  
Author(s):  
Yang Dan
Keyword(s):  
Type Ii Diabetes ◽  
Clinical Observation ◽  
Acupuncture Treatment ◽  
Therapeutic Effects ◽  
Type Ii

scholarly journals Therapeutic effects of Citrullus colocynthis fruit in patients with type II diabetes: A clinical trial study

2016 ◽  
Vol 8 (2) ◽  
pp. 130 ◽  
Author(s):  
Ghobad Abangah ◽  
Batol Barghamdi ◽  
Fereshteh Ghorat ◽  
Khairollah Asadollahi ◽  
Kourosh Sayehmiri ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Type Ii Diabetes ◽  
Therapeutic Effects ◽  
Type Ii ◽  
Citrullus Colocynthis

scholarly journals Acupuncture for the Treatment of Depression and Physical Symptoms in Chronic Bipolar Disorder: A Case Report

2020 ◽  
Vol 13 ◽  
pp. 117954762096737
Author(s):  
Yuto Matsuura ◽  
Yoshinori Watanabe ◽  
Hiroshi Taniguchi ◽  
Yoshihisa Koga ◽  
Fumiko Yasuno ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Case Report ◽  
Acupuncture Treatment ◽  
Psychiatric Symptoms ◽  
Physical Symptoms ◽  
Pharmacological Intervention ◽  
Therapeutic Effects ◽  
Type Ii ◽  
Self Rating ◽  
Mixed Features

Introduction: Bipolar disorder (BD) is typically treated by pharmacotherapy. However, pharmacotherapy alone is often not adequate to cope with the variety of symptoms associated with BD. The present case report describes the therapeutic effects of manual acupuncture on a patient with chronic BD, and multiple concurrent physical symptoms, that did not improve with standard pharmacotherapy. Case: A 41-year-old woman with type II BD presented with depression, anxiety, and multiple physical symptoms. Her symptoms had first appeared 12 years prior, and she was diagnosed with type II BD 3 years after symptom onset. Although she received standard treatment, including medication and psychotherapy, her symptoms did not improve. Acupuncture treatment aimed at improving psychiatric and physical symptoms was performed weekly for 12 weeks. Depression and anxiety symptoms were evaluated using the Himorogi Self-Rating Depression Scale (HSDS) and Himorogi Self-Rating Anxiety Scale (HSAS) respectively. A visual analog scale (VAS) was used to evaluate physical symptoms including diarrhea, insomnia, and general malaise. Outcome measures were evaluated before each treatment. Results: Throughout the course of the acupuncture intervention, no changes were made to the patient’s psychotropic medication regimen. HSDS and HSAS scores decreased after 12 weeks of acupuncture treatment and improvements in all physical symptoms, as measured by the VAS, were observed. Furthermore, psychiatric symptoms with hypomanic or mixed features were not exacerbated. Conclusions: In this patient, acupuncture was effective in improving psychiatric and physical symptoms of type II BD. This non-pharmacological intervention may be a viable option for the treatment of BD-associated symptoms.

scholarly journals Intestinal AMPK modulation of microbiota mediates cross-talk with brown fat to control thermogenesis

2021 ◽  
Author(s):  
Wendong Huang ◽  
Eryun Zhang ◽  
Lihua JIN ◽  
Yangmeng Wang ◽  
Jui Tu ◽  
...  
Keyword(s):  
Adipose Tissue ◽  
Brown Adipose Tissue ◽  
Type Ii Diabetes ◽  
Therapeutic Effects ◽  
Type Ii ◽  
Energy Status ◽  
Cellular Energy ◽  
Nutrient Processing ◽  
Brown Adipose ◽  
Amp Activated Protein Kinase

Abstract The energy-dissipating capacity of brown adipose tissue through thermogenesis can be targeted to improve energy balance. Mammalian 5′-AMP-activated protein kinase (AMPK), a key nutrient sensor for maintaining cellular energy status, is a known therapeutic target for glucose control in Type II diabetes (T2D). Despite current understandings of its well-established roles in regulating glucose metabolism in various tissues, the functions of AMPK in the intestine, an organ for nutrient processing, remain largely unexplored. Using an intestinal epithelium-specific AMPK-null (AMPK-IKO) mouse model, we demonstrated that AMPK in the intestine communicated with brown adipose tissue (BAT) to promote thermogenesis. Mechanistically, we uncovered a novel link between intestinal AMPK activation and BAT thermogenic regulation through modulating the anti-microbial peptide (AMP)-controlled gut microbiota and the metabolites. Our findings identified a new AMPK-mediated mechanism of intestine-BAT communication that may partially underlie the therapeutic effects of AMPK activator metformin (N, N-dimethylbiguanide).

scholarly journals Researches of the assortment of drugs for the treatment of diabetes II type оn the pharmaceutical market of Ukraine

2019 ◽  
pp. 13-23
Author(s):  
I. V. Kovalevska ◽  
O. A. Ruban ◽  
O. M. Yevtushenko
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Strong Dependence ◽  
Pharmaceutical Market ◽  
Antidiabetic Drugs ◽  
Therapeutic Effects ◽  
Minimal Risk ◽  
Type Ii ◽  
Advantages And Disadvantages ◽  
Treatment Of Diabetes

Type II diabetes is a global pandemic, as evidenced by data from a study by the International Diabetes Federation. The disease is a chronic, progressive process with a special metabolic condition that is characterized by hyperglycemia. Therapeutic effects should be aimed at eliminating the main causes of type II diabetes mellitus: insulin secretion dysfunction, a decrease in tissue resistance to insulin, or a combination of these. The aim of the work was to study the range of oral antidiabetic drugs on the pharmaceutical market of Ukraine for the treatment of type II diabetes. The objects of study were drugs used in the treatment of type II diabetes. Studies were conducted using content analysis of official sources of information. In the course of the work, the range of antidiabetic drugs, classification, mechanism of action, cost, main advantages and disadvantages of use were established. It is established that the most common dosage form for the treatment of diabetes are tablets, which occupy more than 90% of the total range of drugs. The lack of modern types of dosage forms in the group A10B is the basis for the creation of new drugs with improved biopharmaceutical and consumer properties. The data obtained indicate a strong dependence of the pharmaceutical market of antidiabetic drugs of Ukraine on imports, with the exception of insulin (А10В). The share of imports in the market in quantitative terms for the period under review amounted to more than 75.86% of the total market volume. It has been established that the use of drugs of the A10B A, A10B F groups with an affordable cost with active therapy contributes to a lower rate of development of diabetes mellitus type II and a high degree of regression to normal glucose, without affecting the fluctuations in body weight. Preparations of the new generation (A10B H, A10B J, A10B X) are highly effective with an insufficient safety profile. The high cost of drugs of these groups makes them inaccessible to the general population. It has been shown that only metformin and voglibosis have a positive effect on body mass fluctuation rates, which will ensure safe and effective glycemic control with minimal risk of hypoglycemia and without weight gain in the treatment of type II diabetes.

Sign in / Sign up

Export Citation Format

Share Document